Unknown

Dataset Information

0

Circulating TGF-?1-Regulated miRNAs and the Risk of Rapid Progression to ESRD in Type 1 Diabetes.


ABSTRACT: We investigated whether circulating TGF-?1-regulated miRNAs detectable in plasma are associated with the risk of rapid progression to end-stage renal disease (ESRD) in a cohort of proteinuric patients with type 1 diabetes (T1D) and normal eGFR. Plasma specimens obtained at entry to the study were examined in two prospective subgroups that were followed for 7-20 years (rapid progressors and nonprogressors), as well as a reference panel of normoalbuminuric T1D patients. Of the five miRNAs examined in this study, let-7c-5p and miR-29a-3p were significantly associated with protection against rapid progression and let-7b-5p and miR-21-5p were significantly associated with the increased risk of ESRD. In logistic analysis, controlling for HbA1c and other covariates, let-7c-5p and miR-29a-3p were associated with more than a 50% reduction in the risk of rapid progression (P ? 0.001), while let-7b-5p and miR-21-5p were associated with a >2.5-fold increase in the risk of ESRD (P ? 0.005). This study is the first prospective study to demonstrate that circulating TGF-?1-regulated miRNAs are deregulated early in T1D patients who are at risk for rapid progression to ESRD.

SUBMITTER: Pezzolesi MG 

PROVIDER: S-EPMC4542435 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Circulating TGF-β1-Regulated miRNAs and the Risk of Rapid Progression to ESRD in Type 1 Diabetes.

Pezzolesi Marcus G MG   Satake Eiichiro E   McDonnell Kevin P KP   Major Melissa M   Smiles Adam M AM   Krolewski Andrzej S AS  

Diabetes 20150430 9


We investigated whether circulating TGF-β1-regulated miRNAs detectable in plasma are associated with the risk of rapid progression to end-stage renal disease (ESRD) in a cohort of proteinuric patients with type 1 diabetes (T1D) and normal eGFR. Plasma specimens obtained at entry to the study were examined in two prospective subgroups that were followed for 7-20 years (rapid progressors and nonprogressors), as well as a reference panel of normoalbuminuric T1D patients. Of the five miRNAs examined  ...[more]

Similar Datasets

| S-EPMC3294310 | biostudies-literature
| S-EPMC7991816 | biostudies-literature
2022-01-19 | MTBLS802 | MetaboLights
| S-EPMC8062489 | biostudies-literature
| S-EPMC5319475 | biostudies-literature
| S-EPMC9254699 | biostudies-literature
2017-04-22 | GSE98043 | GEO
| S-EPMC6861356 | biostudies-literature
| S-EPMC3603950 | biostudies-literature
| S-EPMC6590135 | biostudies-literature